Publicacións (47) Publicacións nas que participase algún/ha investigador/a

2012

  1. 3D 'atomistic' simulations of dopant induced variability in nanoscale implant free In 0.75Ga 0.25As MOSFETs

    Solid-State Electronics, Vol. 69, pp. 43-49

  2. Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat

    Psychopharmacology, Vol. 219, Núm. 3, pp. 783-794

  3. Adaptor protein cerebral cavernous malformation 3 (CCM3) mediates phosphorylation of the cytoskeletal proteins ezrin/radixin/moesin by mammalian Ste20-4 to protect cells from oxidative stress

    Journal of Biological Chemistry, Vol. 287, Núm. 14, pp. 11556-11565

  4. Aplicación de proteómica a la búsqueda de nuevos mecanismos tumorales en cáncer de tiroides

    Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 114-114

  5. Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?

    Clinical and Translational Oncology, Vol. 14, Núm. 5, pp. 386-390

  6. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions

    Cell, Vol. 149, Núm. 4, pp. 871-885

  7. Cellular distribution, regulated expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis

    Endocrinology, Vol. 153, Núm. 4, pp. 1959-1971

  8. Characterization and activity determination of the human protein phosphatase 2A catalytic subunit α expressed in insect larvae

    Applied Biochemistry and Biotechnology, Vol. 167, Núm. 4, pp. 918-928

  9. Comparative study of toxicological and cell cycle effects of okadaic acid and dinophysistoxin-2 in primary rat hepatocytes

    Life Sciences, Vol. 90, Núm. 11-12, pp. 416-423

  10. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 1

  11. Defining stem cell types: Understanding the therapeutic potential of ESCs, ASCs, and iPS cells

    Journal of Molecular Endocrinology, Vol. 49, Núm. 2

  12. Design and synthesis of skeletal analogues of gambierol: Attenuation of amyloid-β and tau pathology with voltage-gated potassium channel and N-Methyl-d-aspartate receptor implications

    Journal of the American Chemical Society, Vol. 134, Núm. 17, pp. 7467-7479

  13. Detection of paralytic shellfish toxins by a solid-phase inhibition immunoassay using a microsphere-flow cytometry system

    Analytical Chemistry, Vol. 84, Núm. 10, pp. 4350-4356

  14. Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin

    PLoS ONE, Vol. 7, Núm. 10

  15. Direct promoter induction of p19Arf by Pit-1 explains the dependence receptor RET/Pit-1/p53-induced apoptosis in the pituitary somatotroph cells

    Oncogene, Vol. 31, Núm. 23, pp. 2824-2835

  16. Effect of gambierol and its tetracyclic and heptacyclic analogues in cultured cerebellar neurons: A structure-activity relationships study

    Chemical Research in Toxicology, Vol. 25, Núm. 9, pp. 1929-1937

  17. Effects of acute exposure to exogenous ammonia on cerebral monoaminergic neurotransmitters in juvenile Solea senegalensis

    Ecotoxicology, Vol. 21, Núm. 2, pp. 362-369

  18. Expression and regulation of chemerin during rat pregnancy

    Placenta, Vol. 33, Núm. 5, pp. 373-378

  19. Growth hormone treatment enhances the functional recovery of sciatic nerves after transection and repair

    Muscle and Nerve, Vol. 45, Núm. 3, pp. 385-392

  20. History and therapeutic use of MAO-A inhibitors: A historical perspective of MAO-A inhibitors as antidepressant drug

    Current Topics in Medicinal Chemistry, Vol. 12, Núm. 20, pp. 2275-2282